These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3253658)

  • 21. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
    Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
    Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
    Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
    Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
    [No Abstract]   [Full Text] [Related]  

  • 23. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Büyükçelik A; Yalçin B; Utkan G; Doruk H
    Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
    [No Abstract]   [Full Text] [Related]  

  • 24. [Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
    Kuribara R; Muroi K; Yoshida M; Suzuki T; Izumi T; Hatake K; Amemiya Y; Miura Y
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1613-7. PubMed ID: 9725058
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    Sepet E; Aytepe Z; Ozerkan AG; Yalman N; Guven Y; Anak S; Devecioglu O; Agaoglu L; Gedikoglu G
    J Clin Pediatr Dent; 1998; 22(3):257-60. PubMed ID: 9641104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publication.
    Schrøder H; Kjeldahl M; Boesen AM; Nielsen OJ; Schmidt K; Johnsen HE; Gregersen H; Heyman M; Gustafsson G
    Dan Med Bull; 2006 Feb; 53(1):76-9. PubMed ID: 16761337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].
    Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Zak J
    Wiad Lek; 2004; 57(7-8):337-42. PubMed ID: 15631188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transverse leukonychia and anti-leukemia chemotherapy].
    Bader-Meunier B; Garel D; Dommergues JP; Venencie PY
    Ann Pediatr (Paris); 1990 May; 37(5):337-8. PubMed ID: 2369052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin manifestation of extramedullary relapse in adult with acute lymphoblastic leukaemia.
    Rudzka E; Holowiecki J; Kachel L; Lawniczek T; Pajak J
    Haematologia (Budap); 1991; 24(4):235-9. PubMed ID: 1844232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    García Zueco JC; Torres Gómez M; López Gómez L; Martín Guerrero Y
    Sangre (Barc); 1992 Apr; 37(2):152-3. PubMed ID: 1621188
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?].
    Schrøder H; Kjeldstad M; Boesen AM; Nielsen OJ; Schmidt KG; Johnsen HE; Gregersen H; Gustafsson G
    Ugeskr Laeger; 2006 Jun; 168(26-32):2554-8. PubMed ID: 16824410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-interferon therapy in advanced unresponsive immunoblastic lymphoma evolved from Waldenström's macroglobulinemia.
    Carella AM
    Haematologica; 1990; 75(6):581. PubMed ID: 1711503
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].
    Ribera JM; Grañena A; Sierra J; Urbano-Ispizua A; Brugués R; Rozman C
    Med Clin (Barc); 1988 Nov; 91(17):653-7. PubMed ID: 3230971
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.